Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment

The research field of systems biology has greatly advanced and, as a result, the concept of network pharmacology has been developed. This advancement, in turn, has shifted the paradigm from a “one-target, one-drug” mode to a “network-target, multiple-component-therapeutics” mode. Network pharmacology is more effective for establishing a “compound-protein/gene-disease” network and revealing the regulation principles of small molecules in a high-throughput manner. This approach makes it very powerful for the analysis of drug combinations, especially Traditional Chinese Medicine (TCM) preparations. In this work, we first summarized the databases and tools currently used for TCM research. Second, we focused on several representative applications of network pharmacology for TCM research, including studies on TCM compatibility, TCM target prediction, and TCM network toxicology research. Third, we compared the general statistics of several current TCM databases and evaluated and compared the search results of these databases based on 10 famous herbs. In summary, network pharmacology is a rational approach for TCM studies, and with the development of TCM research, powerful and comprehensive TCM databases have emerged but need further improvements. Additionally, given that several diseases could be treated by TCMs, with the mediation of gut microbiota, future studies should focus on both the microbiome and TCMs to better understand and treat microbiome-related diseases.

[1]  Y. Kamatani,et al.  Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population , 2011, Gut.

[2]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[3]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[4]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[5]  Shao Li,et al.  [Network target: a starting point for traditional Chinese medicine network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[6]  Peter Kraft,et al.  PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Fernández-arquero,et al.  Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease , 2005, Scandinavian journal of gastroenterology.

[8]  Xing Chen,et al.  A network-based method for mechanistic investigation of Shexiang Baoxin Pill’s treatment of cardiovascular diseases , 2017, Scientific Reports.

[9]  Masashi Kawamura,et al.  Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis , 2007, Journal of gastroenterology and hepatology.

[10]  C. Takahashi,et al.  Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. , 2004, Mutagenesis.

[11]  Liuting Zeng,et al.  A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility , 2016, Evidence-based complementary and alternative medicine : eCAM.

[12]  Feng Tang,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis. , 2015, Journal of ethnopharmacology.

[13]  N. Campbell Genetic association database , 2004, Nature Reviews Genetics.

[14]  Gang Bai,et al.  Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways , 2016, Acta Pharmaceutica Sinica B.

[15]  Bai-xia Zhang,et al.  [Elucidating hypoglycemic mechanism of Dendrobium nobile through auxiliary elucidation system for traditional Chinese medicine mechanism]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[16]  Xuegong Zhang,et al.  Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.

[17]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[18]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[19]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[20]  Na Li,et al.  [Study on effective substance basis and molecular mechanism of Qigui Tongfeng tablet using network pharmacology method]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[21]  Chi-Rei Wu,et al.  The ameliorating effects of LiuWei Dihuang Wang on cycloheximide-induced impairment of passive avoidance performance in rats. , 2007, Journal of ethnopharmacology.

[22]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[23]  Fang Feng,et al.  Network Pharmacology-Based Antioxidant Effect Study of Zhi-Zi-Da-Huang Decoction for Alcoholic Liver Disease , 2015, Evidence-based complementary and alternative medicine : eCAM.

[24]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[25]  Yu Huang,et al.  Ginseng Extracts Restore High-Glucose Induced Vascular Dysfunctions by Altering Triglyceride Metabolism and Downregulation of Atherosclerosis-Related Genes , 2013, Evidence-based complementary and alternative medicine : eCAM.

[26]  Yao Gao,et al.  [An exploration in the action targets for antidepressant bioactive components of Xiaoyaosan based on network pharmacology]. , 2015, Yao xue xue bao = Acta pharmaceutica Sinica.

[27]  Yao Tong,et al.  Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms , 2015, Chinese Medicine.

[28]  Dongyun Yang,et al.  Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. , 2008, Cancer research.

[29]  Jun Xu,et al.  Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction , 2016, Scientific Reports.

[30]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[31]  Christine Hackel,et al.  Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. , 2002, Cancer letters.

[32]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..

[33]  Tao Gong,et al.  An approach based on HPLC-fingerprint and chemometrics to quality consistency evaluation of Liuwei Dihuang Pills produced by different manufacturers. , 2008, Journal of pharmaceutical and biomedical analysis.

[34]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[35]  Marija Matic,et al.  GSTM1 (Glutathione S-transferase M1) , 2017 .

[36]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[37]  Jayne Jones,et al.  Cytokine Gene Polymorphisms in Heavy Drinkers With and Without Decompensated Liver Disease: A Case-Control Study , 2008, The American Journal of Gastroenterology.

[38]  Vladimir Batagelj,et al.  Exploratory Social Network Analysis with Pajek , 2005 .

[39]  Chun-song Zheng,et al.  Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction, and their application in osteoarthritis , 2013, Experimental and therapeutic medicine.

[40]  Liuting Zeng,et al.  Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach. , 2017, Journal of ethnopharmacology.

[41]  Jane Qiu,et al.  Traditional medicine: A culture in the balance , 2007, Nature.

[42]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[43]  Robert S. Sandler,et al.  GSTM1 and GSTT1 Polymorphisms, Cigarette Smoking, and Risk of Colon Cancer: A Population-based Case-control Study in North Carolina (United States) , 2006, Cancer Causes & Control.

[44]  Tamara Cacev,et al.  Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. , 2008, Carcinogenesis.

[45]  Bojana Boh,et al.  Ganoderma lucidum and its pharmaceutically active compounds. , 2007, Biotechnology annual review.

[46]  E. G. de la Concha,et al.  C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease. , 2001, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[47]  Qian Liu,et al.  [Prediction of multi-target of Aconiti Lateralis Radix Praeparata and its network pharmacology]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[48]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[49]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[50]  Li Guochun,et al.  A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout. , 2015, Journal of ethnopharmacology.

[51]  Mauro Santos,et al.  Polymorphisms of alcohol-metabolizing enzymes and the risk for alcoholism and alcoholic liver disease in Caucasian Spanish women. , 2006, Drug and alcohol dependence.

[52]  Yan Li,et al.  Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach. , 2014, Journal of ethnopharmacology.

[53]  Damian Szklarczyk,et al.  STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..

[54]  P J Quesenberry,et al.  The Network , 2019, Leonardo.

[55]  R. Wolff,et al.  PPARγ and Colon and Rectal Cancer: Associations with Specific Tumor Mutations, Aspirin, Ibuprofen and Insulin-Related Genes (United States) , 2006, Cancer Causes & Control.

[56]  Bojana Boh,et al.  Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. , 2013, Recent patents on anti-cancer drug discovery.

[57]  Christine K. Carrico,et al.  Frontiers in pharmacology , 1983 .

[58]  Ting Wang,et al.  Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[59]  Shui-Tein Chen,et al.  Anti-diabetic effects of Ganoderma lucidum. , 2015, Phytochemistry.

[60]  A. Hopkins Network pharmacology , 2007, Nature Biotechnology.

[61]  Bo Zhang,et al.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.

[62]  R. Paterson,et al.  Ganoderma - a therapeutic fungal biofactory. , 2006, Phytochemistry.

[63]  Gourdas Choudhuri,et al.  Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis. , 2009, Mutation research.

[64]  Xue Xu,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.

[65]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[66]  Li Li,et al.  Association between Phosphatidylinositol 3-Kinase Regulatory Subunit p85α Met326Ile Genetic Polymorphism and Colon Cancer Risk , 2008, Clinical Cancer Research.

[67]  Hong Zhou,et al.  An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica – Fritillaria usuriensis dropping pills for pulmonary diseases , 2015, BMC Complementary and Alternative Medicine.

[68]  F. Gloria-Bottini,et al.  ACP1 genetic polymorphism and colon cancer. , 2008, Cancer genetics and cytogenetics.

[69]  T. Karttunen,et al.  IL‐1 RN 2/2 genotype and simultaneous carriage of genotypes IL‐1 RN 2/2 and IL‐1β‐511 T/T associated with oesophagitis in Helicobacter pylori‐negative patients , 2003, Scandinavian journal of gastroenterology.

[70]  Alexandra Pohl,et al.  Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer , 2009, Pharmacogenetics and genomics.

[71]  Chaohui Yu,et al.  Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people. , 2002, Chinese medical journal.

[72]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[73]  Bo Zhang,et al.  A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge-Gen-Qin-Lian Decoction for Treatment of Type 2 Diabetes , 2014, Evidence-based complementary and alternative medicine : eCAM.

[74]  Craig M. Crews,et al.  Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials , 2007, Cell.

[75]  Miguel Marcos,et al.  A new genetic variant involved in genetic susceptibility to alcoholic liver cirrhosis: −330T>G polymorphism of the interleukin-2 gene , 2008, European journal of gastroenterology & hepatology.

[76]  Yan-jiang Qiao,et al.  [Study on mechanism of Salvia miltiorrhiza treating cardiovascular disease through auxiliary mechanism elucidation system for Chinese medicine]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[77]  Zheng Xiang,et al.  The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology. , 2015, Molecular bioSystems.

[78]  Wei Liu,et al.  A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action , 2014, PloS one.

[79]  Dale E. Johnson,et al.  Web resources for drug toxicity. , 2002, Toxicology.

[80]  C. Takahashi,et al.  Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. , 2004, Mutagenesis.

[81]  Xufeng Tao,et al.  Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction , 2016, Front. Pharmacol..

[82]  Na Lin,et al.  Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation , 2016, International journal of biological sciences.

[83]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[84]  Sreeparna Banerjee,et al.  PPARG (peroxisome proliferator-activated receptor gamma) , 2011 .

[85]  Yeong-Deug Yi,et al.  An Overview of Traditional Chinese Herbal Formulae and a Proposal of a New Code System for Expressing the Formula Titles , 2004, Evidence-based complementary and alternative medicine : eCAM.

[86]  J. Chen,et al.  HAPPI: an online database of comprehensive human annotated and predicted protein interactions , 2009, BMC Genomics.

[87]  Yuqing Sun,et al.  Quantitative and qualitative determination of Liuwei Dihuang tablets by HPLC-UV-MS-MS. , 2007, Journal of chromatographic science.

[88]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[89]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[90]  Dongsheng Cao,et al.  A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Bushenhuoxue Formula for Treatment of Chronic Kidney Disease , 2014, PloS one.

[91]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[92]  David Kiefer,et al.  Panax ginseng , 2009 .

[93]  Na Lin,et al.  A Systems Biology-Based Approach to Uncovering the Molecular Mechanisms Underlying the Effects of Dragon's Blood Tablet in Colitis, Involving the Integration of Chemical Analysis, ADME Prediction, and Network Pharmacology , 2014, PloS one.

[94]  Bai-xia Zhang,et al.  [Study on mechanism for anti-depression efficacy of Sini San through auxiliary mechanism elucidation system for Chinese medicine]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[95]  Soon-Tae Lee,et al.  Panax Ginseng Enhances Cognitive Performance in Alzheimer Disease , 2008, Alzheimer disease and associated disorders.

[96]  Hui Sun,et al.  Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. , 2010, Journal of pharmaceutical and biomedical analysis.

[97]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[98]  Liang Fang,et al.  [Application of network pharmacology and high through-put technology on active compounds screening from traditional Chinese medicine]. , 2012, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[99]  Sung Hoon Kim,et al.  Ginseng and Diabetes: The Evidences from In Vitro, Animal and Human Studies , 2012, Journal of ginseng research.

[100]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[101]  Zdenek Kala,et al.  Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus , 2007, Journal of Human Genetics.

[102]  J. Kou,et al.  An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases , 2015, Acta Pharmacologica Sinica.

[103]  Shao Li,et al.  Network Pharmacology in Traditional Chinese Medicine , 2014, Evidence-based complementary and alternative medicine : eCAM.

[104]  Miguel Marcos,et al.  A functional polymorphism of the NFKB1 gene increases the risk for alcoholic liver cirrhosis in patients with alcohol dependence. , 2009, Alcoholism, clinical and experimental research.

[105]  Jong-Hoon Kim,et al.  Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications , 2012, Journal of ginseng research.

[106]  Chih-Jung Chang,et al.  Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota , 2015, Nature Communications.

[107]  K. Chan,et al.  Progress in traditional Chinese medicine. , 1995, Trends in pharmacological sciences.

[108]  Gabriele Ausiello,et al.  MINT: the Molecular INTeraction database , 2006, Nucleic Acids Res..

[109]  Xiaohui Fan,et al.  [Network toxicology and its application to traditional Chinese medicine]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[110]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[111]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[112]  Yi Wang,et al.  Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology , 2014, Chinese Medicine.

[113]  Defeng Li,et al.  Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitis , 2016, International journal of chronic obstructive pulmonary disease.

[114]  Gourdas Choudhuri,et al.  Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis. , 2010, Drug and alcohol dependence.

[115]  David V Conti,et al.  Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. , 2010, Cancer research.

[116]  P Wexler,et al.  TOXNET: an evolving web resource for toxicology and environmental health information. , 2001, Toxicology.

[117]  Ning Wang,et al.  A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets , 2017, International journal of molecular sciences.

[118]  Kang Ning,et al.  TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations , 2017, Scientific Reports.